About: Alemtuzumab

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Alemtuzumab Goto Sponge NotDistinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

scientific article published on 01 December 2007

Attributes	Values
rdf:type	Item
description	наукова стаття, опублікована в грудні 2007 (uk) article scientifique publié en 2007 (fr) artículu científicu espublizáu n'avientu de 2007 (ast) scientific article published on 01 December 2007 (en)
publication date	wds:Q80424228-E3ACD86B-D1C6-4250-8EBD-755FCF0A319C
publication date	2007-12-01 00:00:00Z (xsd:dateTime)
language of work or name	wds:Q80424228-2E0D0B7E-4421-49B0-A249-C1074106B716
language of work or name	English
author name string	wds:Q80424228-CE640083-5E97-4965-8D39-B8E95C1EB9A5 wds:Q80424228-D4F5FEB0-4B74-4EC2-B2A4-24334956B376
author name string	Allan D Kirk Timothy A Weaver
rdfs:label	Alemtuzumab (en)
skos:prefLabel	Alemtuzumab (en)
name	Alemtuzumab (en)
title	wds:Q80424228-C3F6DC75-178D-4731-9353-6EF8663538EC
title	Alemtuzumab (en)
page(s)	wds:Q80424228-5B71647E-4F53-4B27-B74F-E41548D87D9F
page(s)	1545-1547
instance of	wds:Q80424228-4DE30022-028F-4DC6-BB52-8B7DB241F32E
instance of	scholarly article
PubMed ID	wds:Q80424228-AEBFB14E-6B18-4841-B666-6459A89D5A56
PubMed ID	http://rdf.ncbi.nlm.nih.gov/pubchem/reference/18165760
PubMed ID	18165760
published in	wds:Q80424228-89CB7D20-0757-4D5A-B7D6-33FE21D52555
published in	Transplantation
issue	wds:Q80424228-6B404444-CE43-4A4D-85F6-C78ECFEED863
volume	wds:Q80424228-A9515F6E-CE09-469F-A33A-F70483D77875
issue	12
volume	84
DOI	wds:Q80424228-D3948E3D-C38C-4649-9FEA-7B1AC4C7B821
DOI	http://dx.doi.org/10.1097/01.TP.0000296680.75175.67
DOI	10.1097/01.TP.0000296680.75175.67
is about of	https://www.wikidata.org/wiki/Special:EntityData/Q80424228
is cites work of	Disease-specific hematopoietic cell transplantation: nonmyeloablative conditioning regimen for dyskeratosis congenita. Islet transplantation with alemtuzumab induction and calcineurin-free maintenance immunosuppression results in improved short- and long-term outcomes Monoclonal antibody therapy and renal transplantation: focus on adverse effects Alemtuzumab induction in renal transplantation: a meta-analysis and systemic review Lymphocyte modulation with FTY720 improves hemorrhagic shock survival in swine The evolving role of alemtuzumab (Campath-1H) in renal transplantation. Th17 mediated alloreactivity is facilitated by the pre-transplant microbial burden of the recipient Lymphocyte depletion in experimental hemorrhagic shock in Swine. Comparative efficacy and safety of antibody induction therapy for the treatment of kidney: a network meta-analysis
is cites work of	wds:Q36321016-5E901472-4924-48A3-95E5-EEA5820EAB8C wds:Q53330217-99CBA110-E5E6-4A95-AA2C-2E7B07F5ABCF wds:Q26826880-465A055C-DB8B-49CE-85C5-819F0D07B0FC wds:Q37381213-434A1799-3BCA-4186-9EA5-E6D71378514B wds:Q36552330-812A6DC9-0D82-4530-A875-C545344A6D61 wds:Q34256174-917E741A-8498-48A0-A9CF-601BFDB76790 wds:Q42371647-949D9716-1C4C-4109-AF6C-A64032C5F8E0 wds:Q34613973-67581F3B-5C18-4A0A-B8DF-FB55F645C574 wds:Q34409131-1AA71007-02E6-49EB-A697-C1748AF453FA

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 196 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software